Earnings dates and session timing shown here are aggregated from third-party sources, are frequently estimated, and are subject to change or confirmation by the reporting company. Nothing on this site is financial advice.
MAIA Biotechnology Inc. is an innovative biotechnology company focused on developing cutting-edge cancer therapies that significantly improve patient outcomes across various malignancies. Utilizing its proprietary technology platforms, MAIA aims to harness the power of the immune system to create targeted therapies that address critical unmet medical needs in oncology. With a strong development pipeline and a strategic commitment to therapeutic innovation, MAIA is well-positioned to become a prominent participant in the biopharmaceutical sector, capitalizing on emerging growth opportunities within the evolving healthcare landscape.
Quotes and fundamental data are delayed and provided for informational purposes only — nothing on this page is financial advice. Figures are as reported by the company and its data providers and may be revised. Estimates reflect analyst consensus at the time of each report.
$1.31
| Quarter | EPS | Revenue | Price move | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Est | Adj | Result | GAAP | Est | Actual | Surprise | 1D Pre | On-Day | 1D Post | |
Q ended Jun 30, 2026 Reported Aug 10, 2026 | $-0.11 | $-0.13 | Miss -18.2% | $-0.13 | $0 | $0 | — | 1D Pre0.0% | On-Day-0.7% | 1D Post-2.1% |
Q ended Mar 31, 2026 Reported May 11, 2026 | $-0.18 | $-0.14 | Beat +22.2% | $-0.14 | $0 | $0 | — | 1D Pre+0.8% | On-Day-0.8% | 1D Post0.0% |
Q ended Dec 31, 2025 Reported Mar 23, 2026 | $-0.13 | $-0.13 | Met 0.0% | |||||||
Dashed outlines show the analyst consensus estimate for periods where one was published. Hover or tap a bar for exact figures. Values as reported; not adjusted for splits after the report date.
| — |
| $0 |
| $0 |
| — |
| 1D Pre-2.7% |
| On-Day+2.1% |
| 1D Post-3.4% |
Q ended Sep 30, 2025 Reported Nov 7, 2025 | $-0.19 | $-0.27 | Miss -42.1% | — | $0 | $0 | — | 1D Pre-2.7% | On-Day+1.8% | 1D Post+2.7% |